A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...

Blood tests for Alzheimer’s disease are becoming more accurate, but researchers stress the need for caution and further study.

ALZHEIMER’S disease is more widespread than previously thought, a first-of-its-kind study suggests. Using a simple blood test ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A new experimental drug from ...

A study of blood-based markers for Alzheimer’s disease in Norway confirms earlier estimates, and may show how education level ...

And more than one in ten over the age of 70 would meet the criteria for drugs to slow early stages of the disease.

New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...